New Partnership with Biosphere Corporation
We are happy to announce that 1AMD has recently embarked on a significant partnership with Biosphere Corporation, a USA renowned households supplier worldwide. This partnership, formalized in 2023, marks a strategic collaboration. As a pilot project under this partnership is the introduction of the Vortex brand, The success of this initial venture paves the way for the introduction of the many brands under the Biosphere Umbrella in Albania as well. The inclusion of Farmix in this portfolio expansion indicates a robust and diverse range of products being offered to consumers.
Environmental Stewardship
Our companies have taken steps to be more environmentally conscious by installing solar panels. This move towards renewable energy sources is a reflection of the company’s commitment to sustainability and responsible business practices. By harnessing the power of the sun, the company is able to reduce its carbon footprint and minimize its impact on the environment. The installation of solar panels not only demonstrates its commitment to environmental responsibility but also highlights its willingness to invest in innovative technologies that align with its core values. Overall, the family business is taking a holistic approach to business by expanding into new industries, while also prioritizing sustainable practices to minimize its impact on the environment.
Latest Milestones
In 2023, Farmix obtained the rights to launch Curalin, a revolutionary supplement for managing Type 2 diabetes, containing nine natural ingredients, backed by two published clinical trials, and endorsed by Dr. Itamar Raz, a respected international endocrinologist. Notably, Farmix’s professionalism has led both the suppliers in Israel and partner in Serbia to choose GAK as their distributor for North Macedonia. This decision was influenced by GAK’s strong connections and relations with key pharmaceutical profiles
Within three years of collaboration with Pharma One, the GAK has significantly broadened its influence in Albania’s pharmaceutical sector, successfully introducing major industry players like KRKA, Alkaloid, and Novo Nordisk to the local market. KRKA a renowned Slovenian pharmaceutical company, specializing in the production of high-quality generic medicines. Alkaloid based in North Macedonia, a multifaceted company producing pharmaceuticals, chemicals, cosmetics, and botanicals. Novo Nordisk a global leader in diabetes care from Denmark, brings its expertise in innovative diabetes treatments to Albania. This strategic expansion by the GAK underlines their capability in fostering significant partnerships, thus improving access to a range of quality healthcare products and treatments as well as the primary focus of the group that is HEALTHCARE sector.
Furthermore Gak & Partners has skillfully navigated the unique challenges of the Slovenian market during the turbulent Covid years. Demonstrating resilience and adaptability, the company has successfully carved out a substantial market share in the retail sector. This accomplishment is a testament to their strategic planning and ability to adapt to rapidly changing market conditions. Now, with their sights set on Greece, Gak & Partners has already initiated operations and as 2024 approaches, the company stands on the cusp of promising opportunities and potential growth, poised to replicate their success in Slovenia and further solidify their presence in the Eastern European markets.
gak-ks.com 